Abstract
Pseudohypoparathyroidism type Ib (PHP-Ib) is a rare disorder characterized by PTH resistance in the proximal renal tubules, which leads to hypocalcemia, hyperphosphatemia, and an elevated serum PTH level. Resistance to other hormones that mediate their actions through G protein-coupled receptors and evidence for AHO can also be observed but are much less frequently than in pseudohypoparathyroidism type Ia (PHP-Ia). Most variants of PHP-Ib are associated with GNAS methylation changes, thereby reducing maternal expression of the stimulatory G protein (Gsα) in few tissues, where paternal expression of this signaling protein is silenced through as-of-yet unknown mechanisms. In familial PHP-Ib cases, these epigenetic changes are caused by deletions within or upstream of GNAS. Duplication of large portions of the paternal chromosome 20q is observed in a few patients with the sporadic form of the disease, but most of these PHP-Ib cases remain undefined at the molecular level.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albright F, Burnett CH, Smith PH, Parson W (1942) Pseudohypoparathyroidism – an example of “Seabright-Bantam syndrome”. Endocrinology 30:922–932
Albright F, Forbes AP, Henneman PH (1952) Pseudo-pseudohypoparathyroidism. Trans Assoc Am Physicians 65:337–350
Tashjian AH Jr, Frantz AG, Lee JB (1966) Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci U S A 56:1138–1142
Chase LR, Aurbach GD (1967) Parathyroid function and the renal excretion of 3′5′-adenylic acid. Proc Natl Acad Sci U S A 58:518–525
Chase LR, Fedak SA, Aurbach GD (1969) Activation of skeletal adenyl cyclase by parathyroid hormone in vitro. Endocrinology 84:761–768
Chase LR, Melson GL, Aurbach GD (1969) Pseudohypoparathyroidism: defective excretion of 3′,5′-AMP in response to parathyroid hormone. J Clin Invest 48:1832–1844
Marcus R, Wilber JF, Aurbach GD (1971) Parathyroid hormone-sensitive adenyl cyclase from the renal cortex of a patient with pseudohypoparathyroidism. J Clin Endocrinol Metab 33:537–541
Drezner M, Neelon FA, Lebovitz HE (1973) Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclic AMP signal. N Engl J Med 289:1056–1060
Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G, Smallwood PM, Levine MA (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright’s hereditary osteodystrophy. N Engl J Med 322:1412–1419
Weinstein LS, Gejman PV, Friedman E, Kadowaki T, Collins RM, Gershon ES, Spiegel AM (1990) Mutations of the Gs a-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A 87:8287–8290
Davies AJ, Hughes HE (1993) Imprinting in Albright’s hereditary osteodystrophy. J Med Genet 30:101–103
Linglart A, Gensure RC, Olney RC, Jüppner H, Bastepe M (2005) A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am J Hum Genet 76:804–814
Turan S, Fernandez-Rebollo E, Aydin C, Zoto T, Reyes M, Bounoutas G, Chen M, Weinstein LS, Erben RG, Marshansky V et al (2014) Postnatal establishment of allelic galphas silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous galphas disruption. J Bone Miner Res 29:749–760
Yamamoto M, Takuwa Y, Masuko S, Ogata E (1988) Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism. J Clin Endocrinol Metab 66:618–625
Stone M, Hosking D, Garcia-Himmelstine C, White D, Rosenblum D, Worth H (1993) The renal response to exogenous parathyroid hormone in treated pseudohypoparathyroidism. Bone 14:727–735
Linglart A, Fryssira H, Hiort O, Holterhus PM, Perez de Nanclares G, Argente J, Heinrichs C, Kuechler A, Mantovani G, Leheup B et al (2012) PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance. J Clin Endocrinol Metab 97:E2328–E2338
Murray T, Gomez Rao E, Wong MM, Waddell JP, McBroom R, Tam CS, Rosen F, Levine MA (1993) Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. J Bone Miner Res 8:83–91
Ish-Shalom S, Rao LG, Levine MA, Fraser D, Kooh SW, Josse RG, McBroom R, Wong MM, Murray TM (1996) Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism. J Bone Miner Res 11:8–14
Elrick H, Albright F, Bartter FC, Forbes AP, Reeves JD (1950) Further studies on pseudo-hypoparathyroidism: report of four new cases. Acta Endocrinol (Copenh) 5:199–225
Peterman MG, Garvey JL (1949) Pseudohypoparathyroidism; case report. Pediatrics 4:790
Reynolds TB, Jacobson G, Edmondson HA, Martin HE, Nelson CH (1952) Pseudohypoparathyroidism: report of a case showing bony demineralization. J Clin Endocrinol Metab 12:560
Winter JSD, Hughes IA (1980) Familial pseudohypoparathyroidism without somatic anomalies. Can Med Assoc J 123:26–31
Farfel Z, Brickman AS, Kaslow HR, Brothers VM, Bourne HR (1980) Defect of receptor-cyclase coupling protein in pseudohypoparathyroidism. N Engl J Med 303:237–242
Levine MA, Downs RW Jr, Singer M, Marx SJ, Aurbach GD, Spiegel AM (1980) Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun 94:1319–1324
Silve C, Santora A, Breslau N, Moses A, Spiegel A (1986) Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 62:640–644
Schipani E, Weinstein LS, Bergwitz C, Iida-Klein A, Kong XF, Stuhrmann M, Kruse K, Whyte MP, Murray T, Schmidtke J et al (1995) Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 80:1611–1621
Suarez F, Lebrun JJ, Lecossier D, Escoubet B, Coureau C, Silve C (1995) Expression and modulation of the parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in skin fibroblasts from patients with type Ib pseudohypoparathyroidism. J Clin Endocrinol Metab 80:965–970
Fukumoto S, Suzawa M, Takeuchi Y, Nakayama K, Kodama Y, Ogata E, Matsumoto T (1996) Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 81:2554–2558
Bettoun JD, Minagawa M, Kwan MY, Lee HS, Yasuda T, Hendy GN, Goltzman D, White JH (1997) Cloning and characterization of the promoter regions of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene: analysis of deoxyribonucleic acid from normal subjects and patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 82:1031–1040
Jan de Beur S, Ding C, LaBuda M, Usdin T, Levine M (2000) Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes. J Clin Endocrinol Metab 85:2239–2246
Silve C, Jüppner H (2015) Genetic disorders caused by mutations in the PTH/PTHrP receptor and down-stream effector molecules. In: Bilezikian J, Marcus R, Levine MA (eds) The Parathyroids (3rd edition). Academic Press, San Diego, CA 587–605.
Jüppner H, Schipani E, Bastepe M, Cole DEC, Lawson ML, Mannstadt M, Hendy GN, Plotkin H, Koshiyama H, Koh T et al (1998) The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci U S A 95:11798–11803
Bastepe M, Pincus JE, Sugimoto T, Tojo K, Kanatani M, Azuma Y, Kruse K, Rosenbloom AL, Koshiyama H, Jüppner H (2001) Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet 10:1231–1241
Liu J, Litman D, Rosenberg M, Yu S, Biesecker L, Weinstein L (2000) A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest 106:1167–1174
Bastepe M, Fröhlich LF, Hendy GN, Indridason OS, Josse RG, Koshiyama H, Korkko J, Nakamoto JM, Rosenbloom AL, Slyper AH et al (2003) Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest 112:1255–1263
Turan S, Ignatius J, Moilanen J, Kuismin O, Stewart H, Mann N, Linglart A, Bastepe M, Jüppner H (2012) De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases. J Clin Endocrinol Metab 97(12):E2314–E2319
Elli FM, de Sanctis L, Peverelli E, Bordogna P, Pivetta B, Miolo G, Beck-Peccoz P, Spada A, Mantovani G (2014) Autosomal Dominant Pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes Loss of Imprinting at the A/B DMR. J Clin Endocrinol Metab 99(4):E724–E728, jc20133704
Richard N, Abeguile G, Coudray N, Mittre H, Gruchy N, Andrieux J, Cathebras P, Kottler ML (2012) A new deletion ablating NESP55 causes loss of maternal imprint of A/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 97:E863–E867
Bastepe M, Fröhlich LF, Linglart A, Abu-Zahra HS, Tojo K, Ward LM, Jüppner H (2005) Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat Genet 37:25–27
Chillambhi S, Turan S, Hwang DY, Chen HC, Jüppner H, Bastepe M (2010) Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis. J Clin Endocrinol Metab 95:3993–4002
Liu J, Nealon J, Weinstein L (2005) Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB. Hum Mol Genet 14:95–102
Linglart A, Bastepe M, Jüppner H (2007) Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus. Clin Endocrinol (Oxf) 67:822–831
Mantovani G, de Sanctis L, Barbieri AM, Elli FM, Bollati V, Vaira V, Labarile P, Bondioni S, Peverelli E, Lania AG et al (2010) Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab 95:651–658
Cavaco BM, Tomaz RA, Fonseca F, Mascarenhas MR, Leite V, Sobrinho LG (2010) Clinical and genetic characterization of Portuguese patients with pseudohypoparathyroidism type Ib. Endocrine 37:408–414
Fernández-Rebollo E, Pérez de Nanclares G, Lecumberri B, Turan S, Anda E, Pérez de Nanclares G, Feig D, Nik-Zainal S, Bastepe M, Jüppner H (2011) Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib? J Bone Miner Res 26:1854–1863
Fernández-Rebollo E, Lecumberri B, Garin I, Arroyo J, Bernal-Chico A, Goni F, Orduna R, Castano L, Pérez de Nanclares G (2011) New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism. Eur J Endocrinol 163:953–962
Pérez-Nanclares G, Romanelli V, Mayo S, Garin I, Zazo C, Fernandez-Rebollo E, Martinez F, Lapunzina P, Pérez de Nanclares G (2012) Detection of hypomethylation syndrome among patients with epigenetic alterations at the GNAS locus. J Clin Endocrinol Metab 97:E1060–E1067
Maupetit-Mehouas S, Azzi S, Steunou V, Sakakini N, Silve C, Reynes C, Perez de Nanclares G, Keren B, Chantot S, Barlier A et al (2013) Simultaneous hyper- and hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b. Hum Mutat 34:1172–1180
Bastepe M, Lane AH, Jüppner H (2001) Paternal uniparental isodisomy of chromosome 20q (patUPD20q) – and the resulting changes in GNAS1 methylation – as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet 68:1283–1289
Lecumberri B, Fernandez-Rebollo E, Sentchordi L, Saavedra P, Bernal-Chico A, Pallardo LF, Bustos JM, Castano L, de Santiago M, Hiort O et al (2009) Coexistence of two different pseudohypoparathyroidism subtypes (Ia and Ib) in the same kindred with independent Gs{alpha} coding mutations and GNAS imprinting defects. J Med Genet 47:276–280
Bastepe M, Altug-Teber O, Agarwal C, Oberfield SE, Bonin M, Jüppner H (2011) Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib (PHP-Ib). Bone 48:659–662
Dixit A, Chandler KE, Lever M, Poole RL, Bullman H, Mughal MZ, Steggall M, Suri M (2013) Pseudohypoparathyroidism type 1b due to paternal uniparental disomy of chromosome 20q. J Clin Endocrinol Metab 98:E103–E108
Chuzhanova N, Chen JM, Bacolla A, Patrinos GP, Ferec C, Wells RD, Cooper DN (2009) Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair. Hum Mutat 30:1189–1198
Chen JM, Cooper DN, Chuzhanova N, Ferec C, Patrinos GP (2007) Gene conversion: mechanisms, evolution and human disease. Nat Rev Genet 8:762–775
Jan de Beur S, Ding C, Germain-Lee E, Cho J, Maret A, Levine M (2003) Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1. Am J Hum Genet 73:314–322
Mantovani G, Bondioni S, Locatelli M, Pedroni C, Lania AG, Ferrante E, Filopanti M, Beck-Peccoz P, Spada A (2004) Biallelic expression of the Gsalpha gene in human bone and adipose tissue. J Clin Endocrinol Metab 89:6316–6319
Costello JM, Dent CE (1963) Hypo-hyperparathyroidism. Arch Dis Child 38:397–407
Allen EH, Millard FJC, Nassim JR (1968) Hypo-hyperparathyroidism. Arch Dis Child 43:295–301
Frame B, Hanson CA, Frost HM, Block M, Arnstein AR (1972) Renal resistance to parathyroid hormone with osteitis fibrosa: “pseudohypohyperparathyroidism”. Am J Med 52:311–321
Farfel Z (1999) Pseudohypohyperparathyroidism-pseudohypoparathyroidism type Ib. J Bone Miner Res 14:1016
Mantovani G, Bondioni S, Linglart A, Maghnie M, Cisternino M, Corbetta S, Lania AG, Beck-Peccoz P, Spada A (2007) Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 92:3738–3742
Pérez de Nanclares G, Fernández-Rebollo E, Santin I, Garcia-Cuartero B, Gaztambide S, Menendez E, Morales MJ, Pombo M, Bilbao JR, Barros F et al (2007) Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright’s hereditary osteodystrophy. J Clin Endocrinol Metab 92:2370–2373
Mariot V, Maupetit-Mehouas S, Sinding C, Kottler ML, Linglart A (2008) A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J Clin Endocrinol Metab 93:661–665
Unluturk U, Harmanci A, Babaoglu M, Yasar U, Varli K, Bastepe M, Bayraktar M (2008) Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright’s hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. Am J Med Sci 336:84–90
Sanchez J, Perera E, Jan de Beur S, Ding C, Dang A, Berkovitz GD, Levine MA (2011) Madelung-like deformity in pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab 96:E1507–E1511
van Dop C (1989) Pseudohypoparathyroidism: clinical and molecular aspects. Semin Nephrol 9:168–178
Kruse K, Kustermann W (1987) Evidence for transient peripheral resistance to parathyroid hormone in premature infants. Acta Paediatr Scand 76:115–118
Narang M, Salota R, Sachdev SS (2006) Neonatal pseudohypoparathyroidism. Indian J Pediatr 73:97–98
Lee CT, Tsai WY, Tung YC, Tsau YK (2008) Transient pseudohypoparathyroidism as a cause of late-onset hypocalcemia in neonates and infants. J Formos Med Assoc 107:806–810
Manzar S (2001) Transient pseudohypoparathyroidism and neonatal seizure. J Trop Pediatr 47:113–114
Linglart A, Menguy C, Couvineau A, Auzan C, Gunes Y, Cancel M, Motte E, Pinto G, Chanson P, Bougneres P et al (2011) Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N Engl J Med 364:2218–2226
Guo J, Liu M, Yang D, Bouxsein ML, Thomas CC, Schipani E, Bringhurst FR, Kronenberg HM (2010) Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH. Endocrinology 151:3502–3513
Guo J, Song L, Liu M, Segawa H, Miyamoto K, Bringhurst FR, Kronenberg HM, Jüppner H (2013) Activation of a non-cAMP/PKA signaling pathway downstream of the PTH/PTHrP receptor is essential for a sustained hypophosphatemic response to PTH infusion in male mice. Endocrinology 154:1680–1689
Rao DS, Parfitt AM, Kleerekoper M, Pumo BS, Frame B (1985) Dissociation between the effects of endogenous parathyroid hormone on adenosine 3′,5′-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II. J Clin Endocrinol Metab 61:285–290
Srivastava T, Alon US (2002) Stage I vitamin D-deficiency rickets mimicking pseudohypoparathyroidism type II. Clin Pediatr (Phila) 41:263–268
Shriraam M, Bhansali A, Velayutham P (2003) Vitamin D deficiency masquerading as pseudohypoparathyroidism type 2. J Assoc Physicians India 51:619–620
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this chapter
Cite this chapter
Jüppner, H. (2015). Pseudohypoparathyroidism Type Ib (PHP-Ib): PTH-Resistant Hypocalcemia and Hyperphosphatemia Due to Abnormal GNAS Methylation. In: Brandi, M., Brown, E. (eds) Hypoparathyroidism. Springer, Milano. https://doi.org/10.1007/978-88-470-5376-2_34
Download citation
DOI: https://doi.org/10.1007/978-88-470-5376-2_34
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5375-5
Online ISBN: 978-88-470-5376-2
eBook Packages: MedicineMedicine (R0)